Currently browsing category

News

Celon Pharma S.A. is one of Forbes Diamonds 2017

Once again the company was recognised in the prestigious ranking which lists the most dynamically developing enterprises in Poland. This year’s Forbes Diamonds list includes close to 2 400 companies. Celon Pharma S.A. took tenth place in the medium-sized company category in the Mazowieckie voivodeship and took fortieth place in …

Meeting of the CELONKO research project consortium members

On 2 February 2017 the inaugural meeting was held for the research project: Development of modern biomarkers and development of an innovative FGFR kinase inhibitor for the treatment of neoplastic diseases – CELONKO. The meeting included a presentation of the project deliverables to date and the plans for 2017. Aleksandra Stańczak, …

Celon Pharma S.A. is a partner of the SMART-UP Lab Project

Celon Pharma S.A. supports talented students, graduates and doctoral students from Polish research centres. This time it is as a partner of the SMART-UP Lab programme which aims at educating young entrepreneurs and developing innovative projects ready for commercial use in the field of health and active life. We value …

Celon Pharma S.A. nominated for the Master of the Stock Exchange award

A list of 16 companies nominated for the award was composed by the journalists and analysts of “Puls Biznesu” and the Bankier.pl platform. According to Puls Biznesu, Celon Pharma S.A. is one of the eight front runners. The nomination justification especially pointed out the Company’s success associated with its début …

Celon Pharma S.A.’s innovative research and development project among the projects on inflammatory diseases to receive co-financing from the National Centre for Research and Development

The project entitled “Selective JAK inhibitor in treatment of immune diseases” received co-financing in the amount of PLN 21,712,490.32 under the Smart Growth Operational Programme 2014-2020. The aim of the project is preclinical evaluation and clinical development (phase I and IIa trials conducted on patients) of an innovative drug candidate …

Celon Pharma S.A’s Warsaw Stock Exchange IPO

Celon Pharma S.A.’s IPO was held on the main market of the Warsaw Stock Exchange on 17 October 2016. The share price on the first day of trading increased by 17.58 percent. 15,000,000 of B series ordinary shares were introduced into the regulated market of the Warsaw Stock Exchange on …